AIDS-associated Kaposi's sarcoma: Variables associated with survival

Patricia L. Myskowski(Memorial Sloan Kettering Cancer Center), Bijan Safai(Metropolitan Hospital Center), Donna Niedzwiecki(Duke University), Susan E. Krown(Memorial Sloan Kettering Cancer Center), Barbara A. Shurgot, Daniel Kaufman, Lourdes Z. Nisce
Journal of the American Academy of Dermatology
June 1, 1988
10.1016/s0190-9622(88)70138-3
Cited by 29

Related Papers

Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS
|Science|1984|3.6k
Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With <i>KRAS</i> Wild-Type Advanced or Metastatic Colorectal Cancer
|JAMA|2017|891
Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)
|Journal of Clinical Oncology|2010|840
Kaposi sarcoma
|Nature Reviews Disease Primers|2019|707
Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. AIDS Clinical Trials Group Oncology Committee.
|Journal of Clinical Oncology|1989|483